Introduction PEGylated Peptide Characterization represents a comprehensive analytical framework designed to assess batch-to-batch consistency, chemical integrity, structural conformation, and purity […]
PEGylated Peptide Characterization: PEG Heterogeneity, Attachment Site and Purity Read More »
Introduction Non-enzymatic Deamidation and Aspartate Isomerization in Therapeutic Peptides are significant chemical degradation pathways that can modify peptide backbone structure,
Introduction Ion Mobility Mass Spectrometry enables the resolution of co-eluting isomeric peptide impurities by distinguishing gas-phase peptide ions according to
Ion Mobility Mass Spectrometry for Separating Isomeric Peptide Impurities Read More »
Introduction Contract Development and Manufacturing Organizations (CDMOs) implement ICH Q2(R2) and ICH Q14 as an integrated, lifecycle-oriented framework that brings
ICH Q2(R2) and ICH Q14: How CDMOs Apply the Analytical Procedure Lifecycle Read More »
Introduction CDMO Quality Agreements function as legally binding quality management frameworks established under Current Good Manufacturing Practice (CGMP) regulations to
CDMO Quality Agreements: What FDA Guidance Requires and What Sponsors Should Include Read More »
Introduction Analytical Method Transfer Between CDMO Sites is a formal and documented process used to qualify a receiving Contract Development
Introduction Phase-Appropriate CMC Development at a CDMO represents a risk-managed approach to scaling that aligns Chemistry, Manufacturing, and Controls activities
Phase-Appropriate CMC Development at a CDMO: What Changes from Preclinical to Phase III Read More »
Introduction Analytical Characterization for 505(b)(2) Peptide Products provides the comprehensive physicochemical, structural, and functional profile required to establish product safety,
Introduction Peptide-Drug Conjugate (PDC) Characterization Services deliver specialized analytical testing that uses high-resolution mass spectrometry and liquid chromatography to confirm
Introduction The execution of GMP Release and ICH Stability Testing establishes the comprehensive analytical framework necessary to demonstrate that therapeutic
